Comments
Loading...
Estrella Immunopharma (NASDAQ:ESLA) Stock, Earnings Estimates, EPS, And Revenue
Estrella Immunopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.090
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Estrella Immunopharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Estrella Immunopharma (ESLA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Estrella Immunopharma (ESLA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Estrella Immunopharma (NASDAQ:ESLA) reporting earnings?
Estrella Immunopharma (ESLA) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Estrella Immunopharma (NASDAQ:ESLA)?
The Actual EPS was $-0.09, which missed the estimate of $0.00.
What were Estrella Immunopharma’s (NASDAQ:ESLA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.